Cargando…

P18-04. MVA-nef vaccination induces specific T-cell responses exerting functions associated with non-progressive disease in HIV-1 infected individuals

Detalles Bibliográficos
Autores principales:	Kutscher, S, Allgayer, S, Dembek, CJ, Bogner, JR, Goebel, FD, Erfle, V, Cosma, A
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767819/ http://dx.doi.org/10.1186/1742-4690-6-S3-P313

Ejemplares similares

Nef-specific CD45RA+ CD8+ T cells secreting MIP-1β but not IFN-γ are associated with nonprogressive HIV-1 infection
por: Dembek, Claudia J, et al.
Publicado: (2010)

P03-04. Increased virulence of CAEV chimeras expressing Nef and Vpx/Vpr accessory proteins in infected goats
por: Jin, Y, et al.
Publicado: (2009)

HIV-1 Nef targets calnexin: a novel mechanism behind Nef effects on host cell and viral proteins
por: Jennelle, Lucas, et al.
Publicado: (2013)

P20-18. Diversity of Gag and Nef immunodominant regions in Brazilian HIV-1 B and F1 subtypes
por: Côrtes, FH, et al.
Publicado: (2009)

The intracellular detection of MIP-1beta enhances the capacity to detect IFN-gamma mediated HIV-1-specific CD8 T-cell responses in a flow cytometric setting providing a sensitive alternative to the ELISPOT
por: Kutscher, Sarah, et al.
Publicado: (2008)

P09-10. Impact of CTL escape mutations in HIV-1 Nef on viral replication
por: Oniangue-Ndza, C, et al.
Publicado: (2009)

P04-47. High-titer autologous and heterologous neutralizing antibody activity in acute SIV-infection
por: Schweighardt, B, et al.
Publicado: (2009)

Understanding the nature of the Nef requirement for HIV-1 infectivity
por: Rosa, Annachiara, et al.
Publicado: (2013)

P04.18. Current status of the dual medical license holders in Korea
por: Choi, B, et al.
Publicado: (2012)

P19-58 LB. Comparison of the immunogenicity in humans and rhesus macaques of vaccines consisting of DNA priming and MVA boosting and MVA priming and boosting
por: Robinson, HL, et al.
Publicado: (2009)

Critical role of calnexin in Nef-mediated inactivation of ABCA1
por: Jennelle, Lucas, et al.
Publicado: (2011)

Chemotactic activity of HIV-1 Nef for human monocytes
por: Lehmann, MH, et al.
Publicado: (2006)

A single dose of SAAVI MVA-C reboosts rhesus macaques after more than 3 years post DNA-MVA prime-boost vaccination
por: Chege, GK, et al.
Publicado: (2012)

Comparative proteomics of wild-type and nef-deleted HIV-1 particles
por: Brégnard, Christelle, et al.
Publicado: (2011)

Immunogenicity of ChAd63 + MVA ME-TRAP in Senegalese adults
por: Mensah, Victorine, et al.
Publicado: (2014)

Nef interferes with development of thymic T cell precursors: differential mechanisms in HIV and SIV
por: Meuwissen, PJ, et al.
Publicado: (2011)

Impairment of viral replication capacity by nef alleles from HIV elite controllers
por: Mwimanzi, Philip, et al.
Publicado: (2011)

HIV-1 Nef alters podosomes and promotes the mesenchymal migration in human macrophages
por: Vérollet, Christel, et al.
Publicado: (2013)

Functional characterization of HIV-1 Nef proteins with heterologous membrane targeting signals
por: Geist, Miriam M, et al.
Publicado: (2013)

Preclinical evaluation of MVA-MUC1-IL2 in combination with chemotherapy in murine models
por: De Meyer, Micaël, et al.
Publicado: (2013)

HIV-1 Nef compensates for disorganization of the Immunological Synapse by inducing TGN-associated Lck signaling
por: Pan, Xiaoyu, et al.
Publicado: (2011)

P04-04 Non-invasive biomarkers with high discriminant ability indicative of musculoskeletal health with ageing
por: Agyapong-Badu, Sandra, et al.
Publicado: (2022)

P18-12 LB. Phase I clinical trial with a new recombinant MVA-BN(®)-multiantigen vaccine: high responder rate and considerable breadth of immunological response
por: Overton, T, et al.
Publicado: (2009)

P04-31. Abstract withdrawn
Publicado: (2009)

P04-46. Broadly cross-neutralizing activity in plasma of HIV-1 and HIV-2 infected individuals
por: Fenyö, E, et al.
Publicado: (2009)

Humoral immunogenicity of ChAd63_MVA ME-TRAP vaccination in African infants and children
por: Bowyer, Georgina, et al.
Publicado: (2014)

Potential role of HIV-1 Nef and human M6B in HIV-associated neurological disorders
por: Moetter, Jessica, et al.
Publicado: (2010)

P04-04. The specific phospholipid binding and neutralizing activities of the anti-HIV antibody 4E10 are separable
por: Xu, H, et al.
Publicado: (2009)

CYP2B6*18 is associated with nevirpine hypersensitivity independently of HLA-C*04:01 in a Malawian HIV population
por: Carr, Daniel, et al.
Publicado: (2014)

CD4.CD8 ratio decrease in AIDS, explained by a molecular mimicry between African HIV-1 Nef and Notch-1. Nef as a target for vaccine and NF-Kb inhibitors (salicylate, resveratrol,curcumin, epigallocatechine-3-gallate)
por: Tran, Guy MK, et al.
Publicado: (2012)

P04-02. Increased breadth and potency of the neutralizing antibody response among dually-HIV-1-infected individuals
por: Powell, RL, et al.
Publicado: (2009)

OA04-03. Characterization of cell-mediated immune responses generated by recombinant modified vaccinia Ankara (rMVA)-HIV-1 in a phase I vaccine trial
por: Currier, JR, et al.
Publicado: (2009)

Changes of biological properties and pathogenesis of CAEV chimeras expressing Nef and Vpx/Vpr accessory proteins in infected goats
por: Jin, Yuhai, et al.
Publicado: (2009)

P04-16. Orally exposed uninfected individuals have systemic anti-HIV response correlating with partner's viral load
por: Hasselrot, K, et al.
Publicado: (2009)

P04.04. Identifying the evidence gaps in acupuncture, experiences of an international project: good practice in traditional Chinese medicine (GP-TCM)
por: Robinson, N, et al.
Publicado: (2012)

P16-29. HIV Nef-specific T cells: Th1/CTL, Th2 and Th17 responses
por: Montes, M, et al.
Publicado: (2009)

PA04.01. Role of prakruti in vocational guidance
por: Waghulade, Hemangini
Publicado: (2013)

P04.36. Abstract withdrawn from publication
Publicado: (2012)

P04.77. Abstract withdrawn from publication
Publicado: (2012)

P07-04. HIV-1 evolution in mother to child transmission and pediatric disease progression
por: Dispinseri, S, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_sgm39hr2hvqfan4j9k5pl4ejje